← Leaderboards
Roy L Hawke
University Of North Carolina Chapel Hill
$690,706
Attributed
$690,706
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $237.9K · FY2005–10$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$690,706 · 8
By mechanism
R21$606,699 · 1
M01$84,007 · 7
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Donald T Lysle$16,084,309
- Kim L Brouwer$15,343,248
- Philip C Smith$1,688,141
- Michael W Fried$8,954,521
- Craig R Lee$5,134,981
Others in their field
Top investigators on “Source”
- Richard A Gibbs · Baylor College Of Medicine$285,393,445
- David Heimbrook · Leidos Biomedical Research, Inc.$233,184,481
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Jeffrey P Krischer · University Of South Florida$224,745,020
- Albert Lazzarini · California Institute Of Technology$202,317,285
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$155,571,437
Research focus
SourceDrug KineticsLiver DiseasesResourcesResearch PersonnelSitePurposeHepatitis C VirusProceduresMilk ThistleComputer Retrieval Of Information On Scientific Projects DatabaseBaseSafetySilymarinDoseFundingGenotypeGrantClinical TrialsLearningInstitutionChronicUnited States National Institutes Of HealthLiver
Grant awards (12)
CAM Herbal Cocktails for Boosting Antioxident Activity to Treat Liver Disease$237,949
R21 · FY2010 · AT · contact PI
CAM Herbal Cocktails for Boosting Antioxident Activity to Treat Liver Disease$221,250
R21 · FY2009 · AT · contact PI
CAM Herbal Cocktails for Boosting Antioxident Activity to Treat Liver Disease$147,500
R21 · FY2008 · AT · contact PI
CLINICAL TRIAL: SILYMARIN (LEGALON?) IN NON-CIRRHOTIC SUBJECTS WITH CHRONIC HEP$20,125
M01 · FY2008 · RR · contact PI
CYP2B6 GENOTYPE-PHENOTYPE AND THE INFLUENCE OF SEX AND ETHNICITY$9,718
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: EFFECTS OF LIVER DISEASE ON PHARMACOKINETICS OF MILK THISTLE$306
M01 · FY2008 · RR · contact PI
EFFECTS OF LIVER DISEASE ON PHARMACOKINETICS OF MILK THISTLE$17,820
M01 · FY2007 · RR · contact PI
SILYMARIN (LEGALON<) IN NON-CIRRHOTIC SUBJECTS WITH CHRONIC HEP C$3,376
M01 · FY2007 · RR · contact PI
CYP3A5 GENOTYPE ON THE INDUCTION OF CYP3A ACTIVITY IN AFRICAN AMERICAN FEMALES$1,983
M01 · FY2006 · RR · contact PI
CYP3A5 GENOTYPE ON THE INDUCTION OF CYP3A ACTIVITY IN AFRICAN AMERICAN FEMALES$12,566
M01 · FY2005 · RR
CYP3A5 Genotype on the Induction of CYP3A Activity in African American Females$12,736
M01 · FY2004 · RR
Understanding Effects of Major Genetic Polymorphisms on CYP3A4-African Amer Men$5,377
M01 · FY2004 · RR